Atlas Trials

Oral Gallium Maltolate for the Treatment of Relapsed and Refractory Glioblastoma

Clinical trial NCT04319276 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT04319276
Sponsor
Medical College of Wisconsin
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
Glioblastoma
Start date
2022-11-11
Primary completion
2025-02-13
Enrollment
26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.